Revising the European Society of Gastrointestinal Endoscopy (ESGE) research priorities: a research progress update.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 7 4 2021
medline: 29 4 2021
entrez: 6 4 2021
Statut: ppublish

Résumé

One of the aims of the European Society of Gastrointestinal Endoscopy (ESGE) is to encourage high quality endoscopic research at a European level. In 2016, the ESGE research committee published a set of research priorities. As endoscopic research is flourishing, we aimed to review the literature and determine whether endoscopic research over the last 4 years had managed to address any of our previously published priorities. As the previously published priorities were grouped under seven different domains, a working party with at least two European experts was created for each domain to review all the priorities under that domain. A structured review form was developed to standardize the review process. The group conducted an extensive literature search relevant to each of the priorities and then graded the priorities into three categories: (1) no longer a priority (well-designed trial, incorporated in national/international guidelines or adopted in routine clinical practice); (2) remains a priority (i. e. the above criterion was not met); (3) redefine the existing priority (i. e. the priority was too vague with the research question not clearly defined). The previous ESGE research priorities document published in 2016 had 26 research priorities under seven domains. Our review of these priorities has resulted in seven priorities being removed from the list, one priority being partially removed, another seven being redefined to make them more precise, with eleven priorities remaining unchanged. This is a reflection of a rapid surge in endoscopic research, resulting in 27 % of research questions having already been answered and another 27 % requiring redefinition. Our extensive review process has led to the removal of seven research priorities from the previous (2016) list, leaving 19 research priorities that have been redefined to make them more precise and relevant for researchers and funding bodies to target.

Sections du résumé

BACKGROUND
One of the aims of the European Society of Gastrointestinal Endoscopy (ESGE) is to encourage high quality endoscopic research at a European level. In 2016, the ESGE research committee published a set of research priorities. As endoscopic research is flourishing, we aimed to review the literature and determine whether endoscopic research over the last 4 years had managed to address any of our previously published priorities.
METHODS
As the previously published priorities were grouped under seven different domains, a working party with at least two European experts was created for each domain to review all the priorities under that domain. A structured review form was developed to standardize the review process. The group conducted an extensive literature search relevant to each of the priorities and then graded the priorities into three categories: (1) no longer a priority (well-designed trial, incorporated in national/international guidelines or adopted in routine clinical practice); (2) remains a priority (i. e. the above criterion was not met); (3) redefine the existing priority (i. e. the priority was too vague with the research question not clearly defined).
RESULTS
The previous ESGE research priorities document published in 2016 had 26 research priorities under seven domains. Our review of these priorities has resulted in seven priorities being removed from the list, one priority being partially removed, another seven being redefined to make them more precise, with eleven priorities remaining unchanged. This is a reflection of a rapid surge in endoscopic research, resulting in 27 % of research questions having already been answered and another 27 % requiring redefinition.
CONCLUSIONS
Our extensive review process has led to the removal of seven research priorities from the previous (2016) list, leaving 19 research priorities that have been redefined to make them more precise and relevant for researchers and funding bodies to target.

Identifiants

pubmed: 33822332
doi: 10.1055/a-1397-3005
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

535-554

Informations de copyright

European Society of Gastrointestinal Endoscopy. All rights reserved.

Déclaration de conflit d'intérêts

A. Anderloni has provided consultancy for Boston Scientific (2016 to date), Olympus (2018 to present), and Medtronic (2018–2019). M. Barthet has received a research grant from Boston Scientific (2016 to present). P. Bhandari has received educational event support from Olympus, speaker’s fees and grants from Pentax, Medtronic, Boston Scientific, and 3-D Matrix, and is on the advisory board and received a research grant from Fujifilm (all 2017 to present). M. Dinis-Ribeiro has provided consultancy for Medtronic (2020); he is co-Editor-in-Chief of

Auteurs

Pradeep Bhandari (P)

Department of Gastroenterology, Portsmouth University Hospital NHS Trust, Portsmouth, UK.

Gaius Longcroft-Wheaton (G)

Department of Gastroenterology, Portsmouth University Hospital NHS Trust, Portsmouth, UK.

Diogo Libanio (D)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal.

Pedro Pimentel-Nunes (P)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal.

Eduardo Albeniz (E)

Gastroenterology Department, Endoscopy Unit, Complejo Hospitalario de Navarra, Navarrabiomed-UPNA-IdiSNA, Pamplona, Spain.

Mathieu Pioche (M)

Gastroenterology Division, Edouard Herriot Hospital, Lyon, France.

Reena Sidhu (R)

Academic Department of Gastroenterology, Royal Hallamshire Hospital, Sheffield, UK.

Cristiano Spada (C)

Digestive Endoscopy and Gastroenterology, Fondazione Poliambulanza, Brescia, Italy.
Università Cattolica del Sacro Cuore, Rome, Italy.

Andrea Anderloni (A)

Gastroenterology and Digestive Endoscopy Unit, Ospedale dei Castelli, Ariccia, Rome, Italy.

Alessandro Repici (A)

Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Digestive Endoscopy Unit, IRCSS Humanitas Research Hospital, Milan, Italy.

Rehan Haidry (R)

Department of Gastroenterology, University College London Hospitals, London, UK.

Marc Barthet (M)

Department of Gastroenterology, Hôpital Nord, Assistance publique des hôpitaux de Marseille, Marseille, France.

Helmut Neumann (H)

Department of Medicine I, University Medical Center Mainz, Mainz, Germany.
GastroZentrum Lippe, Bad Salzuflen, Germany.

Giulio Antonelli (G)

Gastroenterology and Digestive Endoscopy Unit, Ospedale dei Castelli, Ariccia, Rome, Italy.
Nuovo Regina Margherita Hospital, Rome, Italy.
Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy.

Alberto Testoni (A)

Vita Salute, San Raffaele Hospital, Milan, Italy.

Thierry Ponchon (T)

Gastroenterology Division, Edouard Herriot Hospital, Lyon, France.

Peter D Siersema (PD)

Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Lorenzo Fuccio (L)

Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Cesare Hassan (C)

Nuovo Regina Margherita Hospital, Rome, Italy.

Mario Dinis-Ribeiro (M)

Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH